Abcam Establishes New Direct Service for Australia and New Zealand
News Aug 12, 2014
Abcam plc announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam’s focus on providing the best products and services to accelerate the pace of researchers’ scientific discoveries.
The new service enables customers in Australia and New Zealand to order their research tools directly from Abcam rather than through a distributor. These customers will also benefit from direct technical support, and delivery times reduced by up to 50% from order to delivery.
Philippe Cotrel, Commercial Director, Abcam, said: “I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand. A direct service will enable us to develop closer relationships with our customers, and ensure we are fully meeting their research needs.”
Abcam’s experienced technical and customer support teams and in-house manufacturing facilities provide researchers worldwide with high-performance products that they can trust, such as RabMAb® primaries.
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019